A Randomised Single Blind Controlled Trial to Assess Effect of Amalaki (Emblica Officinalis) 30 CH of Type 2 Diabetes Mellitus Taking Conventional Treatment As Add on Therapy : A Pilot Study . ahr 2022, 4 (4), 43-53.